Nhc Homecare Milan | |
14091 South First Street, Milan, Tennessee 38358 | |
(731) 686-7471 | |
Name | Nhc Homecare Milan |
---|---|
Location | 14091 South First Street, Milan, Tennessee |
Certified By | Medicare |
Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
Medicare ID | 447152 |
Ownership Type | Proprietary |
Service Area Zip Codes | 38001, 38006, 38024, 38059, 38201, 38220, 38221, 38225, 38229, 38230, 38233, 38237, 38242, 38251, 38256, 38257, 38258, 38261, 38301, 38305, 38313, 38316, 38317, 38320, 38321, 38328, 38330, 38333, 38340, 38341, 38343, 38344, 38348, 38351, 38355, 38356, 38358, 38362, 38363, 38366, 38374, 38382, 38391, 38392 |
NPI Number | 1124043914 |
Organization Name | NHC-OP LP |
Address | 14091 S 1st St, Milan, TN 38358 |
Phone Number | 731-686-7471 |
News Archive
Canadian researchers have found that as many as 1 in 25 deaths worldwide can be attributed to alcohol and this rise since 2000 is mainly due to increases in the number of women drinking.
CSL Biotherapies has announced the initiation of the company's first U.S. clinical trials of its candidate Influenza A/H1N1 2009 vaccine. Study investigators will administer vaccinations to the first U.S. study volunteers today, August 24. The studies will determine the safety of CSL's candidate vaccine and its ability to elicit an immune response (also referred to as immunogenicity) in adults and children.
Patients who undergo liver transplantation for hepatitis B-related liver damage should receive lifelong antiviral treatment to keep the disease from coming back.
Scientists who have helped create new hair cells on the skin of mice say hair loss may be reversible.
BD (Becton, Dickinson and Company), a leading global medical technology company, today announced the launch of the first automated phenotypic test to detect and classify carbapenemase-producing organisms (CPO).
› Verified 3 days ago
Quality Rating: |
News Archive
Canadian researchers have found that as many as 1 in 25 deaths worldwide can be attributed to alcohol and this rise since 2000 is mainly due to increases in the number of women drinking.
CSL Biotherapies has announced the initiation of the company's first U.S. clinical trials of its candidate Influenza A/H1N1 2009 vaccine. Study investigators will administer vaccinations to the first U.S. study volunteers today, August 24. The studies will determine the safety of CSL's candidate vaccine and its ability to elicit an immune response (also referred to as immunogenicity) in adults and children.
Patients who undergo liver transplantation for hepatitis B-related liver damage should receive lifelong antiviral treatment to keep the disease from coming back.
Scientists who have helped create new hair cells on the skin of mice say hair loss may be reversible.
BD (Becton, Dickinson and Company), a leading global medical technology company, today announced the launch of the first automated phenotypic test to detect and classify carbapenemase-producing organisms (CPO).
› Verified 3 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often the home health team began their patients’ care in a timely manner | 99.8 | 95.7 |
How often the home health team taught patients (or their family caregivers) about their drugs | 100 | 98.6 |
How often the home health team checked patients’ risk of falling | 100 | 99.6 |
How often the home health team checked patients for depression | 100 | 97.4 |
How often the home health team made sure that their patients have received a flu shot for the current flu season. | 71.2 | 78.7 |
How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 69.7 | 82.2 |
With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 100 | 96.4 |
News Archive
Canadian researchers have found that as many as 1 in 25 deaths worldwide can be attributed to alcohol and this rise since 2000 is mainly due to increases in the number of women drinking.
CSL Biotherapies has announced the initiation of the company's first U.S. clinical trials of its candidate Influenza A/H1N1 2009 vaccine. Study investigators will administer vaccinations to the first U.S. study volunteers today, August 24. The studies will determine the safety of CSL's candidate vaccine and its ability to elicit an immune response (also referred to as immunogenicity) in adults and children.
Patients who undergo liver transplantation for hepatitis B-related liver damage should receive lifelong antiviral treatment to keep the disease from coming back.
Scientists who have helped create new hair cells on the skin of mice say hair loss may be reversible.
BD (Becton, Dickinson and Company), a leading global medical technology company, today announced the launch of the first automated phenotypic test to detect and classify carbapenemase-producing organisms (CPO).
› Verified 3 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often patients got better at walking or moving around | 84 | 79.6 |
How often patients got better at getting in and out of bed | 84.4 | 81.1 |
How often patients got better at bathing | 84.6 | 82.3 |
How often patients’ breathing improved | 85.3 | 82.8 |
How often patients’ wounds improved or healed after an operation | 99.4 | 92.3 |
How often patients got better at taking their drugs correctly by mouth | 83.3 | 75 |
How often home health patients had to be admitted to the hospital | 14 | 15.4 |
How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 19.3 | 13 |
How often physician-recommended actions to address medication issues were completely timely | 99.8 | 94 |
News Archive
Canadian researchers have found that as many as 1 in 25 deaths worldwide can be attributed to alcohol and this rise since 2000 is mainly due to increases in the number of women drinking.
CSL Biotherapies has announced the initiation of the company's first U.S. clinical trials of its candidate Influenza A/H1N1 2009 vaccine. Study investigators will administer vaccinations to the first U.S. study volunteers today, August 24. The studies will determine the safety of CSL's candidate vaccine and its ability to elicit an immune response (also referred to as immunogenicity) in adults and children.
Patients who undergo liver transplantation for hepatitis B-related liver damage should receive lifelong antiviral treatment to keep the disease from coming back.
Scientists who have helped create new hair cells on the skin of mice say hair loss may be reversible.
BD (Becton, Dickinson and Company), a leading global medical technology company, today announced the launch of the first automated phenotypic test to detect and classify carbapenemase-producing organisms (CPO).
› Verified 3 days ago
Question Type: | Rating by Patients |
---|---|
Health team gave care in a professional way | |
Health team communicated well with them | |
Health team discussed medicines, pain, and home safety | |
How patients rated overall care from agency |
News Archive
Canadian researchers have found that as many as 1 in 25 deaths worldwide can be attributed to alcohol and this rise since 2000 is mainly due to increases in the number of women drinking.
CSL Biotherapies has announced the initiation of the company's first U.S. clinical trials of its candidate Influenza A/H1N1 2009 vaccine. Study investigators will administer vaccinations to the first U.S. study volunteers today, August 24. The studies will determine the safety of CSL's candidate vaccine and its ability to elicit an immune response (also referred to as immunogenicity) in adults and children.
Patients who undergo liver transplantation for hepatitis B-related liver damage should receive lifelong antiviral treatment to keep the disease from coming back.
Scientists who have helped create new hair cells on the skin of mice say hair loss may be reversible.
BD (Becton, Dickinson and Company), a leading global medical technology company, today announced the launch of the first automated phenotypic test to detect and classify carbapenemase-producing organisms (CPO).
› Verified 3 days ago
The patient survey data of Nhc Homecare Milan is compared against the national average with the color code indicators: Better than National Average Worse than National AverageExperience Measure | Provider | National Avg. |
---|---|---|
Percent of patients who reported that their home health team gave care in a professional way | 88 | 88 |
Percent of patients who reported that their home health team communicated well with them | 84 | 85 |
Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 84 | 83 |
Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 80 | 84 |
Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 76 | 78 |
News Archive
Canadian researchers have found that as many as 1 in 25 deaths worldwide can be attributed to alcohol and this rise since 2000 is mainly due to increases in the number of women drinking.
CSL Biotherapies has announced the initiation of the company's first U.S. clinical trials of its candidate Influenza A/H1N1 2009 vaccine. Study investigators will administer vaccinations to the first U.S. study volunteers today, August 24. The studies will determine the safety of CSL's candidate vaccine and its ability to elicit an immune response (also referred to as immunogenicity) in adults and children.
Patients who undergo liver transplantation for hepatitis B-related liver damage should receive lifelong antiviral treatment to keep the disease from coming back.
Scientists who have helped create new hair cells on the skin of mice say hair loss may be reversible.
BD (Becton, Dickinson and Company), a leading global medical technology company, today announced the launch of the first automated phenotypic test to detect and classify carbapenemase-producing organisms (CPO).
› Verified 3 days ago
Nhc Homecare Milan Location: 14091 South First Street, Milan, Tennessee 38358 Ratings: Phone: (731) 686-7471 |